Percutaneous transluminal procedure for removing atheromatous plaque from the coronary arteries. Both directional (for removing focal atheromas) and rotational (for removing concentric atheromatous plaque) atherectomy devices have been used.
Endovascular procedure in which atheromatous plaque is excised by a cutting or rotating catheter. It differs from balloon and laser angioplasty procedures which enlarge vessels by dilation but frequently do not remove much plaque. If the plaque is removed by surgical excision under general anesthesia rather than by an endovascular procedure through a catheter, it is called ENDARTERECTOMY.
A technique utilizing a laser coupled to a catheter which is used in the dilatation of occluded blood vessels. This includes laser thermal angioplasty where the laser energy heats up a metal tip, and direct laser angioplasty where the laser energy directly ablates the occlusion. One form of the latter approach uses an EXCIMER LASER which creates microscopically precise cuts without thermal injury. When laser angioplasty is performed in combination with balloon angioplasty it is called laser-assisted balloon angioplasty (ANGIOPLASTY, BALLOON, LASER-ASSISTED).
Radiography of the vascular system of the heart muscle after injection of a contrast medium.
Dilation of an occluded coronary artery (or arteries) by means of a balloon catheter to restore myocardial blood supply.
An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
Techniques using laser energy in combination with a balloon catheter to perform angioplasty. These procedures can take several forms including: 1, laser fiber delivering the energy while the inflated balloon centers the fiber and occludes the blood flow; 2, balloon angioplasty immediately following laser angioplasty; or 3, laser energy transmitted through angioplasty balloons that contain an internal fiber.
The use of ultrasound to guide minimally invasive surgical procedures such as needle ASPIRATION BIOPSY; DRAINAGE; etc. Its widest application is intravascular ultrasound imaging but it is useful also in urology and intra-abdominal conditions.
The veins and arteries of the HEART.
The return of a sign, symptom, or disease after a remission.
Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
Devices that provide support for tubular structures that are being anastomosed or for body cavities during skin grafting.
Use of a balloon catheter for dilation of an occluded artery. It is used in treatment of arterial occlusive diseases, including renal artery stenosis and arterial occlusions in the leg. For the specific technique of BALLOON DILATION in coronary arteries, ANGIOPLASTY, BALLOON, CORONARY is available.
Blocking of a blood vessel by an embolus which can be a blood clot or other undissolved material in the blood stream.
The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION.
A condition that is caused by recurring atheroembolism in the lower extremities. It is characterized by cyanotic discoloration of the toes, usually the first, fourth, and fifth toes. Discoloration may extend to the lateral aspect of the foot. Despite the gangrene-like appearance, blue toes may respond to conservative therapy without amputation.
The main artery of the thigh, a continuation of the external iliac artery.
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
The degree to which BLOOD VESSELS are not blocked or obstructed.
The condition of an anatomical structure's being constricted beyond normal dimensions.
Hospitals organized and controlled by a group of physicians who practice together and provide each other with mutual support.
Lack of perfusion in the EXTREMITIES resulting from atherosclerosis. It is characterized by INTERMITTENT CLAUDICATION, and an ANKLE BRACHIAL INDEX of 0.9 or less.
Motion pictures of the passage of contrast medium through blood vessels.
Coagulation of blood in any of the CORONARY VESSELS. The presence of a blood clot (THROMBUS) often leads to MYOCARDIAL INFARCTION.
Obstruction of flow in biological or prosthetic vascular grafts.
Precordial pain at rest, which may precede a MYOCARDIAL INFARCTION.
The continuation of the femoral artery coursing through the popliteal fossa; it divides into the anterior and posterior tibial arteries.
Radiography of blood vessels after injection of a contrast medium.
Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.
The vein which drains the foot and leg.
The region of the lower limb in animals, extending from the gluteal region to the FOOT, and including the BUTTOCKS; HIP; and LEG.
An alternative to amputation in patients with neoplasms, ischemia, fractures, and other limb-threatening conditions. Generally, sophisticated surgical procedures such as vascular surgery and reconstruction are used to salvage diseased limbs.
Pathologic deposition of calcium salts in tissues.
Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
Endoscopic examination, therapy or surgery performed on the interior of blood vessels.
Analyses for a specific enzyme activity, or of the level of a specific enzyme that is used to assess health and disease risk, for early detection of disease or disease prediction, diagnosis, and change in disease status.
The tunnel in the lower anterior ABDOMINAL WALL through which the SPERMATIC CORD, in the male; ROUND LIGAMENT, in the female; nerves; and vessels pass. Its internal end is at the deep inguinal ring and its external end is at the superficial inguinal ring.
Pathological processes involving any one of the BLOOD VESSELS in the vasculature outside the HEART.
A symptom complex characterized by pain and weakness in SKELETAL MUSCLE group associated with exercise, such as leg pain and weakness brought on by walking. Such muscle limpness disappears after a brief rest and is often relates to arterial STENOSIS; muscle ISCHEMIA; and accumulation of LACTATE.
Elements of limited time intervals, contributing to particular results or situations.
Narrowing or constriction of a coronary artery.
Surgical therapy of ischemic coronary artery disease achieved by grafting a section of saphenous vein, internal mammary artery, or other substitute between the aorta and the obstructed coronary artery distal to the obstructive lesion.
Narrowing below the PULMONARY VALVE or well below it in the infundibuluar chamber where the pulmonary artery originates, usually caused by a defective VENTRICULAR SEPTUM or presence of fibrous tissues. It is characterized by restricted blood outflow from the RIGHT VENTRICLE into the PULMONARY ARTERY, exertional fatigue, DYSPNEA, and chest discomfort.
Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.
A clinically significant reduction in blood supply to the BRAIN STEM and CEREBELLUM (i.e., VERTEBROBASILAR INSUFFICIENCY) resulting from reversal of blood flow through the VERTEBRAL ARTERY from occlusion or stenosis of the proximal subclavian or brachiocephalic artery. Common symptoms include VERTIGO; SYNCOPE; and INTERMITTENT CLAUDICATION of the involved upper extremity. Subclavian steal may also occur in asymptomatic individuals. (From J Cardiovasc Surg 1994;35(1):11-4; Acta Neurol Scand 1994;90(3):174-8)
Stents that are covered with materials that are embedded with chemicals that are gradually released into the surrounding milieu.

Long-term functional status and quality of life after lower extremity revascularization. (1/81)

OBJECTIVE: The objective of this study was to assess the longer term (up to 7 years) functional status and quality of life outcomes from lower extremity revascularization. METHODS: This study was designed as a cross-sectional telephone survey and chart review at the University of Minnesota Hospital. The subjects were patients who underwent their first lower extremity revascularization procedure or a primary amputation for vascular disease between January 1, 1989, and January 31, 1995, who had granted consent or had died. The main outcome measures were ability to walk, SF-36 physical function, SF-12, subsequent amputation, and death. RESULTS: The medical records for all 329 subjects were reviewed after the qualifying procedures for details of the primary procedure (62.6% arterial bypass graft, 36.8% angioplasty, 0.6% atherectomy), comorbidities (64% diabetics), severity of disease, and other vascular risk factors. All 166 patients who were living were surveyed by telephone between June and August 1996. At 7 years after the qualifying procedure, 73% of the patients who were alive still had the qualifying limb, although 63% of the patients had died. Overall, at the time of the follow-up examination (1 to 7.5 years after the qualifying procedure), 65% of the patients who were living were able to walk independently and 43% had little or no limitation in walking several blocks. In a multiple regression model, patients with diabetes and patients who were older were less likely to be able to walk at follow-up examination and had a worse functional status on the SF-36 and a lower physical health on the SF-12. Number of years since the procedure was not a predictor in any of the analyses. CONCLUSION: Although the long-term mortality rate is high in the population that undergoes lower limb revascularization, the survivors are likely to retain their limb over time and have good functional status.  (+info)

Endovascular-assisted versus conventional in situ saphenous vein bypass grafting: cumulative patency, limb salvage, and cost results in a 39-month multicenter study. (2/81)

OBJECTIVE: In this retrospective multicenter study, the results of a minimally invasive method of endovascular-assisted in situ bypass grafting (EISB) versus "open" conventional in situ bypass grafting (CISB) were evaluated with a comparison of primary and secondary patency, limb salvage, and cost. METHODS: Enrolled in this study were 273 patients: 117 underwent CISB (42 femoropopliteal, 75 femorocrural) and 156 underwent EISB (41 femoropopliteal, 115 femorocrural). EISB was performed with an angioscopic Side Branch Occlusion system and an angioscopically guided valvulotome. All the patients underwent follow-up examination with serial color-flow ultrasound scanning. RESULTS: Both groups had similar comorbid risk factors for diabetes mellitus, coronary artery heart disease, hypertension, and cigarette smoking. The primary patency rates (CISB, 78.2% +/- 5% [SE]; EISB, 70.5% +/- 5%; P =.156), the secondary patency rates (CISB, 84.1% +/- 4%; EISB, 82.9% +/- 5%; P =.26), and the limb salvage rates (CISB, 85.8%; EISB, 88.4%; P =.127) were statistically similar, with a follow-up period that extended to 39 months (mean, 16.6 months; range, 1 to 40 months). In veins that were less than 2.5 to 3.0 mm in diameter, the EISB grafts fared poorly, with an increased incidence of early (12-month) graft thromboses (CISB, 10 grafts, 8.5%; EISB, 24 grafts, 15.3%). However, wound complications (CISB, 23%; EISB, 4%; P =.003), mean hospital length of stay (CISB, 6.5 days +/- 4.83; EISB, 3.2 days +/- 3.19; P =.001), and mean hospital charges (CISB, $25,349 +/- $19,476; EISB, $18,096 +/- $14,573; P =.001) were all significantly reduced in the EISB group. CONCLUSION: The CISB and EISB midterm primary and secondary patency and limb salvage rates were statistically similar. In smaller veins (< 2.5 to 3.0 mm in diameter), however, EISB is not appropriate because overly aggressive instrumentation may cause intimal trauma, with resultant early graft failure. With the avoidance of a long leg incision in the EISB group, wound complications and hospital length of stay were significantly reduced, which lowered hospital charges and justified the additional cost of the endovascular instruments. When in situ bypass grafting is contemplated, EISB in appropriate patients is a safe, minimally invasive, and cost-effective alternative to CISB.  (+info)

Peripheral directional atherectomy evaluated with a rotational digital angiography system. (3/81)

BACKGROUND: One of the factors that affect the recurrence rate after peripheral directional atherectomy (DA) is the degree of residual stenosis. A new method of peripheral DA to reduce residual stenoses was evaluated with a rotational digital angiography (RDA) system that provides both angiography and fluoroscopy at multiple projections within 360 degrees. PATIENTS AND METHODS: Between March 1995 and July 1999, severe short segmental stenoses of six iliac arteries and two superficial femoral arteries (SFA) in eight patients were treated with the Simpson DA catheter under RDA system guidance. After pre-procedural RDA evaluation, the first series of DA were performed under ordinary PA fluoroscopic guidance. The residual stenoses were evaluated with RDA. If the residual stenoses exceeded 30%, a second series of DA were performed covering the residual plaque with the cutter window of the DA catheter. To this purpose the fluoroscopy of the RDA system was fixed in the direction in which the residual stenoses were largest and most eccentric. The end point was defined to be a residual stenosis of less than 30% evaluated with the RDA system, and the procedures were repeated until the end point was achieved. RESULTS: Five of six iliac artery lesions were curved at the pre-procedural RDA evaluation. After the first series of DA, only two of six iliac lesions but all SFA lesions achieved the end point. Among the four other iliac lesions, three achieved the end point with one or two additional series of DA using the RDA system guidance to control the selective cuts of the residual plaques. One patient had a residual stenosis of 50% because the procedure could not be completed by balloon rupture of the DA catheter. In the patients with iliac stenoses, there was no final residual stenosis in one, and the range was from 20% to 25% in the four patients. The residual stenoses were located on the greater curvature side of the curved artery in three of these four patients. CONCLUSION: The RDA system is a valuable tool in aiding reduction of the residual stenoses during peripheral DA. Minimal stenoses often remain on the greater curvature side of the wall because the rigid and straight metallic capsule (cylindrical housing) of the Simpson DA catheter does not completely fit the curved wall. This phenomenon was thought to be a mechanical limitation of this device.  (+info)

A randomized comparison of balloon angioplasty versus rotational atherectomy in complex coronary lesions (COBRA study). (4/81)

AIMS: Rotablation is a widely used technique for the treatment of complex coronary artery lesions but is so far only poorly supported by controlled studies. The Comparison of Balloon-Angioplasty versus Rotational Atherectomy study (COBRA) is a multicentre, prospective, randomized trial to compare short- and long-term effects of percutaneous transluminal coronary angioplasty (PTCA) and rotablation in patients with angiographically pre-defined complex coronary artery lesions. METHODS AND RESULTS: At seven clinical sites 502 patients with pre-defined complex coronary artery lesions were assigned to either PTCA (n=250) or rotablation (n=252). Primary end-points were procedural success, 6-month restenosis rates in the treated segments, and major cardiac events during follow-up. Procedural success was achieved in 78% (PTCA), and 85% (rotablation) (P=0.038) of cases. Crossover from PTCA to rotablation was 4% and 10% vice versa (P=0.019). There was no difference between PTCA and rotablation with respect to procedure-related complications such as Q wave infarctions (2.4% each), emergency bypass surgery (1.2% versus 2.4%), and death (1.6% versus 0.4%). However, more stents were required after PTCA (14.9% versus 6.4%, P<0.002), predominantly for bailout or unsatisfactory results. Including bail-out stents as an end-point, the procedural success rates were 73% for angioplasty and 84% for rotablation (P=0.006). At 6 months, symptomatic outcome, target vessel reinterventions and restenosis rates (PTCA 51% versus rotablation 49%, P=0.33) were not different. CONCLUSION: Complex coronary artery lesions can be treated with a high level of success and low complication rates either by PTCA with adjunctive stenting or rotablation. The long-term clinical and angiographic outcome is comparable.  (+info)

Role of the distal balloon protection technique in the prevention of cerebral embolic events during carotid stent placement. (5/81)

BACKGROUND AND PURPOSE: We sought to quantitatively and qualitatively evaluate the release of atheromatous plaque debris induced by carotid stenting procedures. METHODS: Eight patients with severe carotid atheromatous stenoses were treated by stent implantation under distal balloon protection. Blood samplings were obtained after stent deployment in the blood pooled below the inflated protection balloon. The samples were centrifuged and evaluated for plaque debris with the use of light microscopy. The debris release was quantitatively estimated by dividing the total volume of debris obtained by the mean debris size. Five patients without endovascular procedure were used as a control group. RESULTS: The 2 main debris types found were nonrefringent cholesterol crystals (4 to 389 microm; 115 to 8697 in number) and lipoid masses (7 to 600 microm; 341 to 34 000 in number). There was a statistically significant difference compared with the samples obtained in the control group (P:=0.017). CONCLUSIONS: Blood samples collected during stent implantation procedures contain a large quantity of atheromatous plaque debris. This emphasizes the role of distal protection techniques in avoiding migration of this plaque material into the cerebral circulation.  (+info)

A novel approach in treating recurrent bilateral hepaticojejunostomy biliary strictures post-liver transplantation: Successful use of Simpson's atherectomy device. (6/81)

Biliary complications occur in 6% to 34% of patients who undergo orthotopic liver transplantation. Strictures at the anastomosis site or elsewhere in the biliary tract are common. These strictures are amenable to interventional radiological and surgical procedures; however, retransplantation is sometimes an inevitable outcome. An 8-year-old boy received combined liver and kidney transplants May 31, 1998. Hepatic artery thrombosis was diagnosed postoperative day 1 and treated with revascularization. The choledochojejunostomy was revised twice and resulted in a high hepaticojejunostomy. Significant strictures on both the right and left hepatic ducts at the anastomosis site were unsuccessfully treated by multiple interventional radiological procedures. The option of retransplantation was seriously explored. Simpson's atherectomy device was used in a novel approach February 24, 1999, and strictures on both ducts were successfully treated. At 1-year postprocedure, the patient has normal liver function with no evidence of recurrence of the strictures. Further experience with this novel technique is required to assess its role in treating biliary strictures post liver transplantation.  (+info)

Impact of the "stent-when-feasible" policy on in-hospital and 6-month success and complication rates after coronary angioplasty: single-center experience with 17,956 revascularization procedures (1993-1997). (7/81)

This retrospective, observational, single-center study analyzed the results of a "stent-when-feasible" policy in a real-world setting. The study began in the "pre-stent" period (1993) and ended after the beginning of the "routine stent" period (1997). When the 1993 and 1997 global data were compared, the early and 6-month results included significant improvements in the rates of angiographic success (89.3% vs 97.1%), emergency surgical revascularization (1.0% vs 0.3%), freedom from in-hospital major events (91.2% vs 95.9%), and freedom from 6-month major events (77.2% vs 85.1%). The 6-month redo revascularization rate was reduced by almost half for "any catheter intervention" (19.6% vs 10.7%) and was lowest after stent use (7.7% in 1997).  (+info)

Percutaneous transluminal revascularization for renal artery stenosis: Veterans Affairs Puget Sound Health Care System experience. (8/81)

PURPOSE: The safety and efficacy of percutaneous transluminal intervention for renal artery stenosis is improving. This study evaluates the immediate and long-term anatomic and functional outcomes of percutaneous transluminal angioplasty and stenting for atherosclerotic renal artery stenosis in a Veterans Affairs population. METHODS: We performed a retrospective analysis of records from patients who underwent renal artery angioplasty with or without stenting at the Veterans Affairs Puget Sound Health Care System between January 1990 and June 1999. Indications for intervention included hypertension (78%) and rising serum creatinine (78%). Seventy-six patients (74 men, average age of 67 years, range 42-83 years) underwent 88 attempted interventions. Seventy-two percent of contralateral kidneys had significant disease (47% had a >60% stenosis; 16% were nonfunctioning or absent). RESULTS: Of the 88 planned interventions, 86 were successfully performed with placement of 46 stents (52%). Technical success (defined by <30% residual stenosis) was achieved in 78 vessels (89%). The procedure-related complication rate was 5%. Patient mortality by life table analysis was 49% at 5 years. Assisted primary patency rate at 5 years was 100%. Primary and secondary restenosis rates were 37% +/- 8% and 31% +/- 8% at 5 years, respectively. Sixty-eight percent of patients treated for hypertension demonstrated clinical benefit (improved or cured hypertension). This clinical benefit was maintained in 52% of the patients at 5 years, as measured by life table analysis. Serum creatinine was lowered or maintained in 88% of the patients, but this clinical benefit was only maintained in 25% of patients at 5 years. CONCLUSIONS: Transluminal intervention for clinically symptomatic atherosclerotic renal artery stenosis is technically successful and safe. There are excellent assisted-patency and low restenosis rates. There is immediate clinical benefit for most patients, as evidenced by improved control of hypertension and preservation of renal function. However, within 5 years the benefit is not maintained for either hypertension (50%) or renal function (20%). Therefore, although technically successful, functional outcomes after endoluminal intervention are not maintained in the long term.  (+info)

Global Laser Atherectomy Devices Market which allows the consumer to assess the long-term based demand and estimate particular implementations. The increasing growth which is truly expected depending on the analysis gives comprehensive information on the global Laser Atherectomy Devices Market. The drivers and restraints are preparing after the whole awareness of the global Laser Atherectomy Devices industry growth.. Global Laser Atherectomy Devices market research report provides the newest industry data and industry future trends. It permits you to recognize the products and complete users managing Revenue growth and profitability. The Laser Atherectomy Devices industry report lists the leading competitors and provides the game-changing strategic analysis of the key factors driving the market. The report involves the forecasts by 2020-2029 and analysis of significant industry trends, market size, market share forecasts, and profiles of the top Laser Atherectomy Devices industry players.. FREE ...
The research report presents a comprehensive outlook on the Global Laser Atherectomy Devices Market contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications. The Laser Atherectomy Devices Market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving revenue growth and profitability.It furthermore has an assessment of the factors influencing the demand and supply of the associated products and services, and challenges witnessed by market players. Moreover, the report is made with different graphical representation with the precise arrangement of key outlines, strategic diagrams, and descriptive figures based on the reliable ...
[96 Pages Report] Check for Discount on United States Laser Atherectomy Devices Market Report 2017 report by QYResearch Group. In this report, the United States Laser Atherectomy Devices market...
The global Orbital Atherectomy Device Market report provides an accurate investigation of the different patterns and parameters affecting the industrial growth of the Orbital Atherectomy Device market at a global level. An assessment of the effect of the current situation and trends in the market is additionally included to provide an overview of the markets future position. The report provides the detailed information related to the global Orbital Atherectomy Device market dynamics and demonstrates superior forecast for the development of the market and its key competitors Medtronic (Ireland), Philips (Netherlands), Boston Scientific (US), Cardiovascular Systems (US), Straub Medical (Switzerland), BIOTRONIK (Netherlands), C.R. Bard (US), Avinger (US) based on consistent information.. Apply here for the sample copy of the report @: www.99strategy.biz/request-for-sample.html?repid=46491. Furthermore, The report presents a detailed segmentation Peripheral Vascular, Cardiovascular, ...
An atherectomy device is used for removing a restriction in a blood vessel. The atherectomy device includes a cutting portion having a lumen therein, the lumen being sized to track over a guidewire, wherein an outer surface of the cutting portion comprises a cutting surface. An elongate shaping member is cooperable with the cutting portion and is disposed generally longitudinally relative to the cutting portion. The shaping member has an insertion conformation and an expanded conformation. The expanded conformation is radially expanded relative to the insertion conformation. The shaping member is configured to deform the cutting portion from an insertion shape into a cutting shape as the shaping member moves from the insertion conformation to the expanded conformation. A drive shaft is coupled to a proximal end of the cutting portion and is configured to be rotationally driven.
The Global Atherectomy Devices Market is expected to reach USD 894.69 million by 2025, based on a new report by Hexa Reports. The demand for atherectomy de
A rotational atherectomy device for removing a stenotic tissue from a vessel of a patient is disclosed. The device comprises a rotatable, flexible, hollow drive shaft having a fluid impermeable wall defining a fluid impermeable lumen of the drive shaft and, an abrasive element mounted to a distal end portion of the drive shaft proximal to and spaced away from a distal support element formed at a distal end of the drive shaft, the distal support element being inflatable by pressurized fluid which flows in an antegrade direction through said lumen of the drive shaft and is at least partially re-directed into the distal fluid inflatable support element. The distal fluid inflatable support element has an outer wall comprising an outflow opening located such that said outflow opening faces an inner surface of a treated vessel during rotation of the drive shaft so that a flow of fluid through said outflow opening forms a layer of fluid between the outer wall of the rotating fluid inflated distal support
Press release - Market Expertz - Atherectomy Devices Market Size, Share Growth, Trends, Devices, Applications, Competitive Analysis, Industry Expansion Strategies, By 2027 - published on openPR.com
Medtronic has been granted CE mark approval for the HawkOne directional atherectomy system in a lower profile size for treating patients with peripheral artery disease. The new HawkOne 6 Fr provides an effective and easy-to-use treatment option for patients with peripheral artery disease both above and below the knee with a single device. The HawkOne system is designed to remove plaque from the vessel wall and restore blood flow.. Directional atherectomy is an established treatment modality for patients with complex peripheral artery disease to restore patency, maximise luminal gain and preserve future treatment options, says Thomas Zeller, head, Department of Angiology, Universitäts-Herzzentrum Freiburg, Bad Krozingen, Germany. The new smaller HawkOne 6Fr size is an advanced option to treat patients with multi-level peripheral artery disease, addressing lesions of various length, morphology, and location, particularly those below the knee.. The HawkOne system is also designed to enable ...
This medical exhibit illustrates the Atherectomy Procedure. The atherectomy instrument is visualized within the coronary artery shaving away the atherosclerotic plaque .
We treat Peripheral arterial disease with minimally invasive state of the art tools. Often at times patients are treated by surgical bypass when they suffer from blockages in the legs. However we use tools such as CSI atherectomy, SilverHawk atherectomy devices for opening up these blocked vessels ...
However, being able to visualize the vessel with the lumivascular technology is clearly appealing and suggestive of safe passage. Distal embolization remains a major concern (especially atherectomy for ISR), and questions the need for embolic protection every time (filter was used only in 22% of patients in the DEFINITVE LE trial).7 Unprecedented complications can arise, which require expertise and catheter skills and may lead to the possibility of open vascular surgery in these high-risk patients.. DA in ISR lesions have been contraindicated due to the potential risk of cutter entrapment on stent struts during atherectomy. However, with the advent of concurrent imaging during DA, this risk can potentially be avoided. Nevertheless, as seen in this case, despite adequate visualization with OCT imaging, there can be significantly malapposed stent struts in overlapped segments that may still pose a risk for trapping the DA catheter. In such scenarios, the use of adjunctive balloon angioplasty ...
Evidence-based recommendations on percutaneous laser atherectomy with balloon angioplasty (with or without stenting) for peripheral arterial disease (PAD)
Evidence-based recommendations on percutaneous laser atherectomy with balloon angioplasty (with or without stenting) for peripheral arterial disease (PAD)
An atherectomy apparatus and method is disclosed for the purpose of surgical excision of atheromas which typically consist of plaque deposits that cause narrowing (stenosis) of an artery. The apparatus, called a pullback atherectomy catheter, cuts and collects obstructive material into a collection chamber as the catheter is pulled back through obstructive material within a human vessel such as an artery.
An atherectomy system for cutting, ingesting and removing an obstruction from within a patients artery, comprising a flexible guide-wire insertable into the artery, a flexible rotary-catheter rotatably disposed and slidable over the flexible guide-wire, a blade forming a distal end of the flexible rotary-catheter having teeth on its periphery which are bent inward, a continuous passage for ingesting the cut obstruction material between the flexible rotary-catheter and the flexible guide-wire, means at the proximal end of the flexible rotary-catheter for rotating it and positive displacement pump means connected to the continuous passage to pull the cut obstruction material proximally.
Avinger has received 510(k) clearance from the US Food and Drug Administration (FDA) for an enhanced version of its Pantheris lumivascular atherectomy system, an image-guided atherectomy device for the treatment of peripheral arterial disease. Avinger will commence US commercialisation of this enhanced version of Pantheris immediately, which the company says features improved ergonomics, physician controls and manufacturability.. Lumivascular technology utilised in the Pantheris system allows physicians to see from inside the artery during a directional atherectomy procedure by using optical coherence tomography (OCT). In the past, physicians have had to rely solely on X-ray as well as touch and feel to guide their tools while they try to treat complicated arterial disease. With the lumivascular approach, physicians can more accurately navigate their devices and treat peripheral arterial disease lesions, thanks to the OCT images they see from inside the artery, according to an Avinger press ...
An atherectomy catheter is provided having a tissue collection chamber capable of being cleaned out in a simple, fast and effective way, and also provides methods of using said catheter to remove material from a blood vessel lumen. In one embodiment the tissue collection chamber has an expandable tip having a first closed position capable of retaining material in the chamber and having a second open position that may allow expulsion of material from the chamber. In a second embodiment the tissue collection chamber has a displaceable tip having a first closed position to retain material in the chamber and having a second open position to allow expulsion of material from the chamber.
A vascular catheter includes a flexible catheter body having proximal and distal ends and an elongate housing secured to the distal end of the catheter body. An interactional device is disposed on one side of the housing, and at least two spaced-apart inflatable chambers are located on the other side of the housing generally at its proximal and distal ends, respectively. The inflatable chambers may be expanded simultaneously or separately, and the spaced-apart positioning of the chambers provides for stable positioning of the housing during atherectomy procedures, imaging procedures, and the like. The balloon is conveniently connected to the housing by an integral flange structure which is secured through an inflation aperture on the housing side. The balloon may be inflated through an annular inflation which is defined by a separate isolation tube disposed in the central lumen of the catheter body.
ECCENTRIC ABRADING HEAD FOR HIGH-SPEED ROTATIONAL ATHERECTOMY DEVICES - The invention provides a rotational atherectomy device having, in various embodiments, a flexible, elongated, rotatable drive shaft with at least one flexible eccentric enlarged abrading head attached thereto. In other embodiments, the eccentric abrading head is not flexible or partially flexible. At least part of the eccentric enlarged cutting head has a tissue removing surface-typically an abrasive surface. In certain embodiments, the abrading head will be at least partially hollow. When placed within an artery against stenotic tissue and rotated at sufficiently high speeds the eccentric nature of the enlarged cutting head causes the cutting head and drive shaft to rotate in such a fashion as to open the stenotic lesion to a diameter substantially larger than the outer diameter of the enlarged cutting head. Preferably the eccentric enlarged cutting head has a center of mass spaced radially from the rotational axis of the ...
An arterial catheter system for removing plaque from the aorta and other arteries is disclosed. The system typically includes an elongate catheter member, a filtration apparatus disposed within the di
A cylindrical housing has a plurality of seriate slots. A helical cutter is rotatably mounted within the housing. A drive wire passes through the housing and connects with the cutter to provide rotational movement to the cutter. Plaque is caught between the slots and the blades of the rotating cutter, cut away from the arterial wall, ground up and flushed out through a catheter.
A system and method for opening a lumen in an occluded blood vessel, e.g., a coronary bypass graft, of a living being. The system comprises an atherectomy catheter having a working head, e.g., a rotary impacting impeller, and a debris extraction sub-system. The atherectomy catheter is located within a guide catheter. The working head is arranged to operate on, e.g., impact, the occlusive material in the occluded vessel to open a lumen therein, whereupon some debris may be produced. The debris extraction sub-system introduces an infusate liquid at a first flow rate adjacent the working head and withdraws that liquid and some blood at a second and higher flow rate, through the guide catheter to create a differential flow adjacent the working head, whereupon the debris is withdrawn in the infusate liquid and blood for collection outside the beings body. The introduction of the infusate liquid may also be used to establish an unbalanced flow adjacent the working head to enable the atherectomy catheter to
I aligned the tailstock with the laser, and then adjusted the extension on the tailstock to make sure it was lined up. It looked great. I slid the tailstock back a little bit, and checked it again. I repeated this process multiple times until the last 4 of the ways - and saw some drift. There was some slight warping from the heating. I should have used a scraper to remove the warp, but I instead used a bastard file. It took a couple of runs at it before it brought it back in line (it was about 0.05 off). I am now the proud owner of a completely operational 534.0601 wood lathe with the metal turning attachment ...
Endovascular interventions have significantly evolved over the past decades. Since the initial application of plain balloon or percutaneous transluminal angioplasty, several novel endovascular approaches and devices have been released on the market (for example, bare metal stents, cryoplasty, atherectomy devices, stent‐grafts, drug‐eluting stents, and drug‐eluting balloons). In general these devices have been studied in relatively small and selected patient populations, often not including CLI patients.62 The only RCT directly comparing open bypass surgery with endovascular therapy (ie, plain balloon angioplasty) in CLI patients is the BASIL trial, which overall showed no differences between the treatment groups with respect to AFS at 1 and 3 years of follow‐up based on an intention‐to‐treat analysis.4 Patients allocated to the open bypass surgery group surviving for more than 2 years after the initial procedure had improved AFS (adjusted HR 0.37; 95% CI 0.17-0.77; P=0.008) and ...
An improved expandable removal element (16) for an atherectomy device wherein the expandable removal element (16) is movable between an expanded position and a contracted position. In one embodiment o
The acquisition of Spectranetics will further expand and strengthen Philips Image-Guided Therapy Business Group. Spectranetics is a leader in vascular intervention to treat coronary and peripheral artery disease, and in lead management for the minimally invasive removal of implanted pacemaker and implantable cardioverter defibrillator (ICD) leads. Spectranetics is currently growing double digits and projects 2017 sales to be in the range of US$293 million to US$306 million.. Spectranetics device portfolio includes a range of laser atherectomy catheters for treatment of blockages with laser energy in both coronary and peripheral arteries; the AngioSculpt scoring balloon used to mechanically push a blockage aside in both peripheral and coronary arteries; the AngioSculptX scoring balloon, which is the only drug-coated scoring balloon in the market, and the Stellarex drug-coated balloon, which treats common to complex lesions while inhibiting the recurrence of these blockages. All of these market ...
Laser atherectomy combined with DCB angioplasty is associated with improved oney-year outcomes for the treatment of Tosaka II and III femoropopliteal in-stent ...
The Willis-Knighton Heart & Vascular Institute provides the following Peripheral Vascular Disease Treatments Carotid Stents, Abdominal Aortic Aneurysm Stent Grafts, Renal Angioplasty & Stents, Peripheral Laser Atherectomy and Cryo-Balloon Angioplasty.
At Mission Vascular & Vein Institute Dr. Pedro Mego is equipped to treat even the most severe P.A.D. cases. With equipment such as SilverHawk, Pheonix, Diamondback360, and laser therapy Dr. Mego is able to tailor an invasive or non-invasive procedure to each individual patient.
Beretta a390 replacement shotgun forearms: used 40 caliber beretta gun price beretta silverhawk 20 gauge beretta 92 defects beretta automatic model date mfg. Some very powerful pistols are gas operated, or pack mule invariably had a Dutch.
The present invention provides an atherectomy catheter which has a cutting element that is able to cut both soft tissue and hard tissue, and methods of cutting material from a blood vessel lumen using a rotating cutting element. The cutting element has a sharp cutting edge that surrounds a cup-shaped surface and at least one surface of abrasive material. The cup-shaped surface directs the cut material into a tissue chamber. The cutting edge and the cup-shaped surface together are well suited to cut and remove relatively soft tissue from the blood vessel. The abrasive material surface in combination with the cutting element is well suited to abrade and remove hard material from the blood vessel.
This Histri was built automatically but not manually verified. As a consequence, the Histri can be incomplete or can contain errors ...
TY - JOUR. T1 - Abrupt vessel closure after directional coronary atherectomy. AU - Popma, Jeffrey J.. AU - Topol, Eric J.. AU - Hinohara, Tomoaki. AU - Pinkerton, Cass A.. AU - Baim, Donald S.. AU - King, Spencer B.. AU - Holmes, David R.. AU - Whitlow, Patrick L.. AU - Kereiakes, Dean J.. AU - Hartzler, Geoffrey O.. AU - Kent, Kenneth M.. AU - Ellis, Stephen G.. AU - Simpson, John B.. PY - 1992/6. Y1 - 1992/6. N2 - From October 1, 1986 to December 31, 1989 directional coronary atherectomy was performed during 1,020 procedures (1,140 lesions) at 14 clinical centers. Abrupt vessel closure, defined as a total coronary occlusion or subtotal occlusion associated with clinical evidence of myocardial ischemia, occurred in 43 procedures (4.2%). It developed in the catheterization laboratory in 34 patients, but was delayed 1 to 96 h after directional atherectomy in 9 patients. By univariate analysis the incidence of abrupt closure was higher in directional atherectomy of de novo lesions (p , 0.001), ...
Atherectomy is a minimally invasive endovascular surgery technique for removing atherosclerosis from blood vessels within the body. It is an alternative to angioplasty for the treatment of peripheral artery disease, but the studies that exist are not adequate to determine if it is superior to angioplasty. It has also been used to treat coronary artery disease, albeit ineffectively. Atherectomy is used to treat narrowing in arteries caused by peripheral artery disease. Unlike angioplasty and stents, which push plaque into the vessel wall, atherectomy cuts plaque from the wall of the artery. While atherectomy is usually employed to treat arteries it can be used in veins and vascular bypass grafts as well. Atherectomy falls under the general category of percutaneous revascularization, which implies re-canalizing blocked vasculature via a needle puncture in the skin. The most common access point is near the groin through the common femoral artery (CFA). Other common places are the brachial artery, ...
Atherectomy led to better postprocedural luminal dimensions but was similar to angioplasty for 6-month outcomes in left anterior descending coronary arteries. Coronary atherectomy, endoluminal stenting, and laser angioplasty are alternative interventions to balloon angioplasty (PTCA) for the percutaneous revascularization of obstructive CAD. They were developed because of the persistent unacceptably high restenosis rate (30% to 50%) associated with PTCA. The Coronary Angioplasty versus Excisional Atherectomy Trial (CAVEAT) by Topol and colleagues and the Canadian Coronary Atherectomy Trial (CCAT) by Adelman and colleagues are important because they are the first randomized trials to compare PTCA with an alternative intervention device. In fact, only 2 other randomized trials with PTCA have been reported: the Angioplasty Compared to Medicine (ACME) trial in patients with single-vessel disease and the Randomized Intervention Treatment of Angina (RITA) trial comparing PTCA with bypass graft ...
Directional atherectomy was associated with a trend toward lower rates of restenosis at 6 months, and increased mortality and ischemic events at one year. DCA resulted in higher rates of early complications at a higher cost and with no clinical benefit. Paradoxically, initial dissemination of these study results produced a transient increase in use of directional atherectomy at CAVEAT-I sites. Among investigators in the trial, there may have been a lack of influence of trial data on clinical practice patterns 1 year after publication of the results.. ...
TY - JOUR. T1 - Comparative early and nine-month results of rotational atherectomy, stents, and the combination of both for calcified lesions in large coronary arteries. AU - Hoffmann, Rainer. AU - Mintz, Gary S.. AU - Kent, Kenneth M.. AU - Pichard, Augusto D.. AU - Satler, Lowell F.. AU - Popma, Jeffrey J.. AU - Hong, Mun K.. AU - Laird, John R.. AU - Leon, Martin B.. PY - 1998/3/1. Y1 - 1998/3/1. N2 - The aim of this study was to determine the preferred treatment modality for calcified lesions in large (≤3 mm) coronary arteries, resulting in the largest lumen dimensions and the most favorable late clinical responses. Three hundred six lesions in 306 patients (223 men, mean age 66 ± 11 years) were treated with either rotational atherectomy plus adjunct balloon angioplasty (n = 147), Palmaz-Schartz stents (n = 103), or a combination of rotational atherectomy plus adjunct Palmaz-Schartz stents (n = 56). The procedural success rate was 98.0% to 98.6% for each treatment modality. Minimal lumen ...
View details of top coronary atherectomy hospitals in Chennai. Get guidance from medical experts to select best coronary atherectomy hospital in Chennai
In addition to compressing and reshaping atheroma, atherectomy excises tissue and debulks plaques; it was anticipated that this mechanism would result in a lower rate of restenosis than that occurring after angioplasty. These expectations were not fulfilled in this trial. Although the procedural success rate was somewhat higher and the postprocedure lumen larger in patients treated with atherectomy, lumen dimensions, restenosis rates and clinical outcomes were similar in the two groups at six months. Clinical outcomes for the two groups were similar at up to 18 months after the procedure.. ...
TY - JOUR. T1 - Coronary angioplasty versus excisional atherectomy trial. T2 - CAVEAT. AU - Holmes, David. AU - Garratt, Kirk N.. AU - Topol, Eric J.. PY - 1992/1/1. Y1 - 1992/1/1. KW - Coronary angioplasty. KW - Exasional atherectomy. UR - http://www.scopus.com/inward/record.url?scp=0026575986&partnerID=8YFLogxK. UR - http://www.scopus.com/inward/citedby.url?scp=0026575986&partnerID=8YFLogxK. U2 - 10.1016/0167-5273(92)90170-8. DO - 10.1016/0167-5273(92)90170-8. M3 - Editorial. C2 - 1572733. AN - SCOPUS:0026575986. VL - 35. SP - 143. EP - 146. JO - International Journal of Cardiology. JF - International Journal of Cardiology. SN - 0167-5273. IS - 2. ER - ...
TY - GEN. T1 - Assessment of possible thermal damage of tissue due to atherectomy by means of a mechanical debulking device. AU - Lovik, Ryan D.. AU - Abraham, John P.. AU - Sparrow, Ephraim M. PY - 2009/12/1. Y1 - 2009/12/1. N2 - In vitro and cadaver experiments, coupled with numerical simulations, were performed to assess the possibility mat orbital atherectomy might cause thermal damage of tissue. The experiments involved debulking operations on a surrogate artery and on the plaque-lined posterior tibial artery of a cadaver. Temperatures and coolant flow rates measured during these experiments enabled a numerical simulation of the debulking of a plaque-lined artery in a living human. The temperature variations from the numerical simulations were used to evaluate a thermal injury index. The resulting values of the index were found to be several orders of magnitude below the threshold value for thermal injury. It is concluded that it is extremely unlikely that the use of an orbital debulking ...
Arteriogram and Atherectomy Baltimore, MD - Minimally Invasive Vascular Center offers Arteriogram and Atherectomy services. Our practice serves Baltimore, MD, Laurel, MD, Silver Spring, MD and the surrounding areas.
Methods: The average age of the 40 patients (32 men, 8 women) included in this study was 65.4±9.1 years. The average occlusion length was 17.5 cm (range: 12-25 cm). The initial recanalization attempts were performed with stiff Terumo guidewires (curved or straight) supported by various catheters (straight/multipurpose/Cobra). After the unsuccessful attempt, an excimer laser catheter (catheter diameters from 1.7-2.5 mm) was used for recanalization using the step-by-step method of crossing. After successful crossing, balloon dilatation was performed in all cases. Stent implant was required in 10% (4/40) of procedures. Patients were followed for 12 months with colour-coded Duplex sonography (CCDS ...
Based in Atlanta, GA, Discovery is a leading health information services provider and one of the nations largest processors of third party medical record requests, including Release of Information, (ROI), and has agreements with hospitals, clinics and physician practices in over 40 states as a Health Information Handler, (HIH). They address the needs of both healthcare providers and authorized requestors to manage the rapidly expanding demand to fulfill HIPAA regulated patient, governmental, insurance, legal, and audit requests for medical records. Using a comprehensive, technology based solutions approach, they address the complexities and regulatory aspects of satisfying patient confidentiality while helping their customers reduce compliance risks, improve productivity and enhance profitability. Reach Discovery at (678) 990-5300 or visit - www.discoveryhrs.com ...
Rotational atherectomy by rotablator. The rotablator pulverize the calcified plaque of atheroma. Here, example of a coronary artery. - Stock Image C002/7142
Clinical Cases in Coronary Rotational Atherectomy: Complex Cases and Complications This concise practical guide is designed to facilitate the clinical
SYSTEM AND METHOD OF USE FOR AGENT DELIVERY AND REVASCULARIZING OF GRAFTS AND VESSELS - A system and method for opening a lumen in an occluded blood vessel, e.g., a coronary bypass graft, of a living being. The system comprises an atherectomy catheter having a working head, e.g., a rotary impacting impeller, and a debris extraction sub-system. The atherectomy catheter is located within a guide catheter. The working head is arranged to operate on, e.g., impact, the occlusive material in the occluded vessel to open a lumen therein, whereupon some debris may be produced. The debris extraction sub-system introduces an infusate liquid at a first flow rate adjacent the working head and withdraws that liquid and some blood at a second and higher flow rate, through the guide catheter to create a differential flow adjacent the working head, whereupon the debris is withdrawn in the infusate liquid and blood for collection outside the beings body. The introduction of the infusate liquid may also be used ...
Endovascular Today sat down with a multidisciplinary panel of esteemed interventionists to discuss their current practice paradigms for atherectomy, including the hot topic of Vessel Prep prior to drug-coated balloons and other adjunctive therapies.
COLORADO SPRINGS, Colo., June 4, 2014-- A presentation by principal investigator Eric J. Dippel, MD, of Genesis Heart Institute in Davenport, Iowa, at the annual New Cardiovascular Horizons conference in New Orleans last week demonstrated significant procedural advantage of laser atherectomy in the largest randomized trial of atherectomy ever conducted.
SilverHawk Plaque Excision: Early Experience in Infrapopliteal Disease and Limb Salvage, Vascular Interventional Advances (VIVA), Mandalay Bay, NE, October 19, 2000.. Second Annual Primer on Peripheral Arterial Disease: An Interventional Course for Advanced Angioplasty Fellows, Cincinnati, OH, September 12-13, 2000.. First Annual Primer on Peripheral Arterial Disease: An Interventional Course for Advanced Angioplasty Fellows, Cincinnati, OH, September 8-11, 1999.. Acute Coronary Syndrome, University of Cincinnati, Cincinnati, OH, May 1999 ...
Fingerprint Dive into the research topics of Balloon postdilation can safely improve the results of successful (but suboptimal) directional coronary atherectomy. Together they form a unique fingerprint. ...
Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The companys Orbital Atherectomy Systems treat calcified and fibrotic plaque in arterial vessels throughout the leg and heart in a few minutes of treatment time, and address many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. The U.S. FDA granted the first 510(k) clearance for the use of the Orbital Atherectomy System in peripheral arteries in August 2007. In October 2013, the company received FDA approval for the Coronary Orbital Atherectomy System. To date, over 356,000 of CSIs devices have been sold to leading institutions across the United States.
In February 2021, Cardiovascular Systems, Inc. (CSI) announced that PT. Revass Utama Medika signed an exclusive distribution agreement to sell its coronary and peripheral Orbital Atherectomy Systems in Indonesia.. Bio-Excel (Australia) Pty. Ltd.:. →Australia. In March 2021, Cardiovascular Systems, Inc. (CSI) announced that Bio-Excel Co. Ltd. signed an exclusive distribution agreement to sell its coronary and peripheral Orbital Atherectomy Systems in Australia.. RSK Medical Inc.. →Canada. In April 2021, Cardiovascular Systems, Inc. (CSI) announced that RSK Medical Inc. signed an exclusive sales agent agreement to sell its coronary and peripheral Orbital Atherectomy Systems in Canada.. ...
Blog post by bluespruce - Here are a few scanned photos of our previous garden at Purewell, Christchurch, in Dorset, as you can see the house and garden are typical Victorian t
Aortic & Peripheral Vascular net sales for the three and six months ended October 27, 2017 were $452 million and $891 million, respectively, an increase of 5 percent and 4 percent, respectively, as compared to the corresponding periods in the prior fiscal year. Aortic & Peripheral Vascular net sales growth for the three and six months ended October 27, 2017 was driven by strong performance in drug-coated balloons and success of the Endurant IIs aortic stent graft, as well as success of the Heli-FX EndoAnchor System. For the three months ended October 27, 2017, net sales growth was also driven by Percutaneous Transluminal Angioplasty (PTA) balloons and the recent launch of Concento 3D detachable coil system, as well as the Valiant Captiva thorasic stent graft systems. Continued strong adoption of the HawkOne 6 French directional atherectomy system also contributed to net sales growth for the three and six months ended October 27, 2017. ...
An elongate tubular body extends between a rotatable cutter and a control. The cutter is connected to the control with a rotatable element and has a serrated surface. A vacuum is applied through an annular passage defined between the tubular body and the rotatable element. The control has an indicator that reveals resistance to rotation and/or reduction in flow. Material that has been processed by the cutter is aspirated through the tubular body for disposal. The control enables rotation of the rotatable element only following application of a predetermined level of vacuum.
cleared coronary balloon on the market-is critical for physicians treating highly complex coronary lesions. As the market leader in coronary atherectomy, the 1.0mm balloon complements our orbital atherectomy system as we continue providing advanced solutions for treating the complex and high-risk indicated patient. At launch, CSI will offer both the 1.0-4.0mm Sapphire II PRO and the 2.0-4.0mm Sapphire® NC Plus non-compliant coronary balloons on a limited basis. The company anticipates that OrbusNeichs full balloon product portfolio will become available in the U.S. throughout 2018 and 2019. About OrbusNeich OrbusNeich is a global pioneer in the provision of life-changing vascular solutions and offers an extensive portfolio of products that set industry benchmarks in vascular intervention. Current products include the worlds first dual therapy stents, the COMBO Plus and COMBO Dual Therapy Stents, together with stents and balloons marketed under the names of Azule®, Scoreflex®, Sapphire® ...
Anna-Maria Belli speaks about how important it is that interventional radiologys clinical responsibility is acknowledged by IR having admitting rights, beds, junior teams and clinics.
TemREN is used to prepare the lesion area for balloon angioplasty and to relieve heavy plaque burden from atherosclerotic lesions. TemREN is usually made up of art...
Insights from the authors on removing severe superficial calcium to achieve significant luminal gain in femoropopliteal arteries.
EMEA (Europe, Middle East, Africa). In July 2018, Cardiovascular Systems, Inc. (CSI®) announced that OrbusNeich Medical Co. Ltd. signed an exclusive distribution agreement to sell its coronary and peripheral Orbital Atherectomy Systems outside the United States and Japan.. Medikit Co., Ltd:. →Japan. In November 2016, Cardiovascular Systems, Inc. (CSI®) announced that Medikit, Co., Ltd. signed an exclusive distribution agreement to sell its coronary and peripheral Orbital Atherectomy Systems in Japan.. ...
Fumedica AG, Atherectomy, Ballon, Bergebeutel, Chirurgische Messer, Clips, Fixationen für Katheter, Hämorrhoidalleiden, Herniennetze, Herzunterstützung, Lungenunterstützung, Inkontinenz, Kardiotechnik, WarmAir, Blanketrol III, Nahtmaterial, Occluder, Patientenüberwachung, Ports, Sternumverschluss, Teflon Pledgets, Stent, Patienten Lagerung Proneview, Zangen, Instrumente
While atherectomy is usually employed to treat arteries it can be used in veins and vascular bypass grafts as well. Atherectomy ... Directional atherectomy is an intravascular procedure guided by optical coherence tomography termed as lumivascular atherectomy ... The use of atherectomy instead of or in addition to angioplasty remains an area of controversy, as atherectomy typically ... Atherectomy is a minimally invasive technique for removing atherosclerosis from blood vessels within the body. It is an ...
Sharma, Samin K.; Kini, Annapoorna S. (1999). "Coronary Atherectomy". Contemporary Concepts in Cardiology. Developments in ...
He also performs rotational atherectomy, an alternative to angioplasty for complex, calcified coronary lesions. He has ... "Rotational Atherectomy Combined With Cutting Balloon to Optimize Stent Expansion in Calcified Lesions". Samin Sharma, M.D., F.A ... refractory angina and rotational atherectomy. A partial listing of his awards and recognition includes Businessman of the Year ... "North American Expert Review of Rotational Atherectomy". Circulation: Cardiovascular Interventions. 12 (5): e007448. doi: ...
Atherectomy Pulmonary thromboendarterectomy Thompson, Jesse E. (August 1996). "The Evolution of Surgery for the Treatment and ...
Atherectomy Cardiopulmonary bypass Coronary stenting Revascularization Portals: India Medicine "Doctor Profile". My Doc Advisor ... Rotational and Directional Atherectomy, Coronary stenting and Percutaneous Laser Myocardial Revascularization. He graduated in ...
Any blood flow-limiting blockage found in the X-ray can be identified and treated by procedures including atherectomy, ... Procedures used to treat the disease include bypass grafting, angioplasty, and atherectomy. In 2015, about 155 million people ...
Often, peripheral angioplasty is used in conjunction with guide wire, peripheral stenting and an atherectomy. Angioplasty can ... "Percutaneous Angioplasty Versus Atherectomy for Treatment of Symptomatic Infra-Popliteal Arterial Disease". Cardiovascular ...
"Aminophylline for Preventing Bradyarrhythmias During Orbital or Rotational Atherectomy of the Right Coronary Artery". ... Atherectomy of the right coronary artery]. It is also used in the treatment of heart block due to acute inferior myocardial ...
Any stenoses found may be treated by the use of balloon angioplasty, stenting, or atherectomy. Fluorescein angiography is a ...
He is the first cardiologist in the region to perform an angioscopy and directional atherectomy. He is reported to be the first ... Atherectomy Drug Eluting Stents Ventricular assist device Angioscopy Embolectomy Transmyocardial revascularization India portal ...
An atherectomy is an invasive procedure performed for removing atherosclerosis from blood vessels within the body. The narrowed ...
Implantation of stents Debulking strategies Rotational atherectomy Orbital atherectomy Laser atherectomy Brachytherapy (use of ... orbital and laser atherectomy. However, coronary intravascular lithotripsy using acoustic shockwaves is a novel approach for ...
It is a form of PCI and generally what is implied when referring to "PCI." Atherectomy - Enlarging the lumen of an artery by ...
Modern endovascular approaches to treating atherosclerosis can include combinations of angioplasty, stenting, and atherectomy ( ...
Patients choosing to have angioplasty and atherectomy are usually discharged 24-48 hours after the procedure and, in most cases ... For some patients, intervention such as coronary angioplasty or atherectomy may serve as possible alternatives to bypass ...
On July 19, 1991, Kirby underwent a coronary atherectomy to open a blockage in an artery just above his heart. After the ...
A large number of procedures can be performed on the heart by catheterization, including angiogram, angioplasty, atherectomy, ...
Atherectomy, stenting, and angioplasty to remove or push aside the arterial blockages are the most common procedures for ...
Additional techniques include atherectomy (removal of plaque from lesions), thrombectomy (removal of clots from vessels) and ... atherectomy, clot removal and distal embolic protection. While at BI, he also served as acting director of the coronary care ... coronary atherectomy and thrombectomy, intra-coronary stents, distal embolic protection devices, and evaluation of new devices ... coronary atherectomy, thrombectomy, distal protection devices, stents and percutaneous valve therapies. Now in its 8th edition ...
Plus Orbital Atherectomy Diamondback® 360 Orbital Atherectomy System (distributor in key territories; manufactured by ... Orbital Atherectomy Stealth® 360 Orbital Atherectomy System (distributor in key territories; manufactured by Cardiovascular ...
Angioplasty balloons Atherectomy lasers and rotational devices Left atrial appendage occlusion devices Electrophysiology:[ ...
... balloons or as in atherectomy procedures. The low viscosity of CO2 makes it easy to pass through small vessels, visualizing ...
... atherectomy MeSH E02.148.050.120.125 - atherectomy, coronary MeSH E02.148.102.060 - angioplasty, balloon MeSH E02.148.102.060. ...
This procedure is different from Rotoblation (Percutaneous Transluminal Rotational Atherectomy or PCRA) whereby a diamond ... STENTS AND ATHERECTOMY (Cleveland Clinic) v t e (CS1 maint: uses authors parameter, Vascular procedures, Medical equipment, All ...
... atherectomy MeSH E04.100.814.050.120.125 - atherectomy, coronary MeSH E04.100.814.055 - angioscopy MeSH E04.100.814.143 - ... atherectomy, coronary MeSH E04.100.376.719.332 - coronary artery bypass MeSH E04.100.376.719.332.199 - coronary artery bypass, ... atherectomy, coronary MeSH E04.928.220.520.220 - coronary artery bypass MeSH E04.928.220.520.220.189 - coronary artery bypass, ...
Percutaneous angioplasty or atherectomy of precerebral (extracranial) vessel(s) (01) Incision and excision of skull, brain, and ...
SILVER SPRING, MD - Boston Scientific is voluntarily recalling two core wires for its Rotablator Rotational Atherectomy System ... Cite this: FDA: Guidewires for Rotablator Atherectomy Catheter Recalled - Medscape - Dec 01, 2015. ...
... or directional coronary atherectomy is a minimally invasive procedure to remove blockage from coronary arteries to improve ... DCA, or directional coronary atherectomy is a minimally invasive procedure to remove blockage from coronary arteries to improve ...
... and what to expect from an atherectomy, a heart procedure. ... What is an atherectomy?. Atherectomy is a minimally invasive ... Atherectomy is useful in situations where hard plaque, with a lot of calcium, is blocking an artery. Removal of this blockage ... It takes around two hours to complete an atherectomy procedure with additional time for preparation and recovery. ...
Coronary AtherectomyCoronary Atherectomy is a procedure that removes fatty material (plaque) from your coronary arteries so ... Coronary Atherectomy is a procedure that removes fatty material (plaque) from your coronary arteries so more blood can get to ... Coronary Atherectomy. Please note: reference image is displayed in place of Flash media. ...
Jetstream™ Atherectomy System Jetstream™ is a rotational atherectomy system. It is engineered to predictably treat real-world ... ROTAPRO™ Rotational Atherectomy The standard in Rotational Atherectomy. The ROTAPRO™ System provides an excellent option for ...
... s assist surgeons in critical care of patients with arterial calcium build up. A motor powered, rotating ...
A catastrophic injury does more than cause harm. It changes lives. Not just for the victim, but for their families, as well. Our clients come from all walks of life, with different backgrounds and experiences. But they all share one thing: Theyve seen a needless, preventable injury turn their world upside down.. ...
Temple Health refers to the health, education and research activities carried out by the affiliates of Temple University Health System (TUHS) and by the Lewis Katz School of Medicine at Temple University. TUHS neither provides nor controls the provision of health care. All health care is provided by its member organizations or independent health care providers affiliated with TUHS member organizations. Each TUHS member organization is owned and operated pursuant to its governing documents ...
Even though rotational atherectomy is contraindicated in vein graft interventions, it can be successfully used in selected ... During the second attempt the next day, rotational atherectomy was used for plaque modification as the lesion appeared ... Successful angioplasty of saphenous venous graft in-stent restenosis using rotational atherectomy ... Successful angioplasty of saphenous venous graft in-stent restenosis using rotational atherectomy ...
Atherectomy and angioplasty are methods that can be used to open arteries without surgery. ... Atherectomy (Laser) Overview. In this minimally-invasive procedure, a catheter equipped with a laser tip is used to remove ... Laser atherectomy is typically most appropriate for the removal of softer types of plaque. ...
In Vitro Assessment of Arterial Compliance of Calcified Regions After Orbital Atherectomy Using Optical Coherence Tomography1 ... Atherectomy systems were developed with the intent of removing plaque and increasing arterial lumen size. An additional benefit ... "In Vitro Assessment of Arterial Compliance of Calcified Regions After Orbital Atherectomy Using Optical Coherence Tomography." ...
Through case review they present examples for how they treat advanced peripheral arterial disease using Phoenix atherectomy and ... share an overview of the mechanism of action of Phoenix atherectomy and the basics of IVUS image interpretation. ... Benefits of laser atherectomy in various morphologies Feat. C. Mena, R. Kovach ... Benefits of laser atherectomy in various morphologies Feat. C. Mena, R. Kovach ...
Effect of orbital atherectomy in calcified coronary artery lesions as assessed by optical coherence tomography ... Effect of orbital atherectomy in calcified coronary artery lesions as assessed by optical coherence tomography Wiley Online ... Objectives We sought to assess plaque modification and stent expansion following orbital atherectomy (OA) for calcified lesions ...
Figure 5: The use of Excimer Laser Coronary Atherectomy in a Calcific Undilatable Lesion John Rawlins, Jehangir Din, Suneel ... Figure 5: The use of Excimer Laser Coronary Atherectomy in a Calcific Undilatable Lesion / ... Figure 5: The use of Excimer Laser Coronary Atherectomy in a Calcific Undilatable Lesion ...
... and the price range for Atherectomy in Bangalore. ... the lowest cost and top doctors and hospitals for Atherectomy ... Atherectomy in Kolkata Atherectomy in Mumbai Atherectomy in Navi Mumbai Atherectomy in Noida Atherectomy in Pune Atherectomy in ... Atherectomy in Ahmedabad Atherectomy in Bangalore Atherectomy in Chennai Atherectomy in Delhi Atherectomy in Faridabad ... Atherectomy in Ghaziabad Atherectomy in Gurgaon Atherectomy in Hyderabad ...
Rotational atherectomy is offered at Apex Cardiology in Jackson, Tennessee. ... Atherectomy is a procedure to remove plaques on the inner walls of the arteries. ... Plaque can be removed by a procedure called atherectomy.. Indications for Atherectomy. Atherectomy is indicated for narrowed ... Home / Patient Info / Conditions & Procedures / Interventional Cardiology / Rotational Atherectomy Rotational Atherectomy. ...
Tag: Atherectomy Devices Market. Article Wood - Bloggers Unite India Articles.. Atherectomy Devices Market Forecast to 2030 ... Atherectomy Devices Market 2022 The atherectomy devices market is likely to grow at a 8.10% CAGR during forecast, reveals the ... Atherectomy devices are widely used to treat peripheral arterial disease and coronary disease. Every device is designed ...
Atherectomy Devices Market: Drivers, Restraints, Opportunities, and Challenges. Atherectomy Devices Market: Drivers, Restraints ... Factors such as increasing availability of reimbursements for atherectomy devices, growing adoption of atherectomy devices ... The report studies the global atherectomy devices market over the forecast period of 2017 to 2022. The market is projected to ... North America is expected to dominate the atherectomy devices market in 2017. Geographically, the market is segmented into ...
Are you looking for an experienced Atherectomy Doctor in Miami Beach? We have helped countless people like yourself with a wide ... the first step you must take is to contact a Atherectomy Doctor in Miami Beach. A Atherectomy Doctor will be able to determine ... Our Atherectomy Doctor has successfully treated countless patients who suffered from a wide range of vascular conditions, and ... Atherectomy Doctor in Miami Beach , Call (305) 504-8667. Vivid Vascular provides patients with the highest quality vascular ...
Best low-cost and yet high-quality Atherectomy for atherosclerosis treatment in Thailand for medical tourism patients in ... Best Atherectomy for atherosclerosis treatment in Thailand (Cardiothoracic surgery). Best low-cost and yet high-quality ... Compare international Cardiothoracic surgery hospitals and ask about the total cost of the Atherectomy for atherosclerosis ... Atherectomy for atherosclerosis treatment in Thailand for medical tourism patients. ...
Documentation of Transient Microvascular Dysfunction Caused by Percutaneous Transluminal Coronary Rotational Atherectomy With ... Documentation of Transient Microvascular Dysfunction Caused by Percutaneous Transluminal Coronary Rotational Atherectomy With ... Documentation of Transient Microvascular Dysfunction Caused by Percutaneous Transluminal Coronary Rotational Atherectomy With ... Documentation of Transient Microvascular Dysfunction Caused by Percutaneous Transluminal Coronary Rotational Atherectomy With ...
Double-wire atherectomy technique was used in 4 patients, although 7 had an additional wire in the side branch during post- ... In conclusion, directional atherectomy can be performed safely and successfully for dilatation of complex bifurcation lesions ... Gambhir DS, Petkar S, Trehan V, Nair M, Bhargava M, Kumar RA, Khalilullah M. Directional atherectomy for the dilatation of ... Directional atherectomy for the dilatation of bifurcation stenoses in the coronary arteries. ...
Atherectomy Devices Market Size was US$ 1.3 Billion in 2021. Industry Trends, Growth, Insight, Impact of COVID-19, Company ... Atherectomy Devices Market Size was US$ 1.3 Billion in 2021. Industry Trends, Growth, Insight, Impact of COVID-19, Company ...
This live case highlights high-risk PCI involving a calcified graft lesion treated with orbital atherectomy and stenting with ... Access & Closure, Atherectomy, CAMP PCI™, Case Review, Intravascular Imaging, Protected PCI Live Case: High-Risk PCI with ... The lesion was successfully ablated with orbital atherectomy and a stent was placed in the proximal graft yielding an excellent ... Anticipating the need for atherectomy, the team decided to proceed electively with hemodynamic support and an Impella was ...
... share an overview of the mechanism of action of Phoenix atherectomy and the basics of IVUS image interpretation. ... Micah Watts, MD, FSIR, and Sarang Mangalmurti, MD, FACC, share an overview of the mechanism of action of Phoenix atherectomy ... Through case review they present examples for how they treat advanced peripheral arterial disease using Phoenix atherectomy and ...
Know about Coronary Directional Atherectomy - The diagnostic procedure in which the plaque in coronary arteries is shaved from ... The reasons for ordering directional atherectomy are the same as for rotational atherectomy. ... The preparations are similar to those made for the rotational atherectomy. What happens during the procedure?. The procedure ... Directional atherectomy is a procedure during which the plaque in your coronary arteries is shaved from the arterial walls. ...
... in its pivotal clinical trial to evaluate the safety and effectiveness of the DABRA excimer laser system as an atherectomy ... Ra Medical Systems provides update on enrolment in pivotal atherectomy clinical trial. 21st February 2022. 4873 ... The open-label pivotal atherectomy clinical trial can enroll subjects with symptoms of PAD (Rutherford Class 2-5) at up to 10 ... The FDA defines atherectomy to include a prespecified improvement in luminal patency. ...
Laser atherectomy is a technology that helps in dealing with certain kinds of blockages that cannot be removed using ... Chennai Based Doctor Proctors the First Laser Atherectomy in India. February 4, 2021. adminUncategorized ... Arun Kalyanasundaram was the first proctor in United States for laser atherectomy and was involved in the seminal study where ... Arun Kalyanasundaram, one of Indias renowned cardiologists, has successfully proctored Indias first laser atherectomy to treat ...
Atherectomy and angioplasty are methods that can be used to open arteries without surgery. There are several different devices ... Home/Tests, procedures and surgery/Atherectomy/angioplasty of noncoronary vessel. Tests, procedures and surgery Atherectomy/ ... Atherectomy or angioplasty of noncoronary vessel - Definition. Atherectomy and angioplasty are methods that can be used to open ... Atherectomy or angioplasty of noncoronary vessel - Possible Complications. If you are planning to have an atherectomy or ...
  • Through case review they present examples for how they treat advanced peripheral arterial disease using Phoenix atherectomy and intravascular ultrasound (IVUS) to inform their decision making. (vumedi.com)
  • Atherectomy devices are widely used to treat peripheral arterial disease and coronary disease. (articlewood.com)
  • Atherectomy is a minimally invasive procedure similar to angioplasty. (heartandstroke.ca)
  • Even though rotational atherectomy is contraindicated in vein graft interventions, it can be successfully used in selected cases when routine angioplasty techniques fail. (bmj.com)
  • Although bifurcation lesions in the coronary arteries can be dilated with balloon angioplasty, directional atherectomy is emerging as the treatment of choice in patients with large arteries. (who.int)
  • Double-wire atherectomy technique was used in 4 patients, although 7 had an additional wire in the side branch during post-atherectomy balloon angioplasty. (who.int)
  • Atherectomy is sometimes used as a complement to angioplasty and stenting where hardened plaques are first removed to an extent to allow the insertion of the balloon and stent, which then widen the artery. (apexcardio.com)
  • Laser atherectomy is a technology that helps in dealing with certain kinds of blockages that cannot be removed using traditional method of balloon angioplasty/stents. (bharathanews.com)
  • Atherectomy and angioplasty are methods that can be used to open arteries without surgery. (mednhealth.com)
  • Atherectomy or angioplasty of noncoronary vessel - How Long Will It Take? (mednhealth.com)
  • Atherectomy or angioplasty of noncoronary vessel - How Much Will It Hurt? (mednhealth.com)
  • [24] Procedures used to treat the disease include bypass grafting , angioplasty , and atherectomy . (wikipedia.org)
  • Follow step-by-step recommendations using angiography or intravascular imaging for treatment using balloon angioplasty, atherotomy, or atherectomy before provisional or dual-stent techniques from our BifurcAID app based on lesion and vessel morphology. (cardiologyapps.com)
  • Prognostic impact of scoring balloon angioplasty after rotational atherectomy in heavily calcified lesions using second-generation drug-eluting stents: A multicenter registry-based study. (twmu.ac.jp)
  • There are numerous devices used in the field of interventional cardiology such as catheters, guide wires, Angioplasty Balloons, Stents, Vascular Closure Devices, Atherectomy Devices, Intravascular Ultrasound and Fractional Flow Reserve. (verifiedmarketresearch.com)
  • Cite this: FDA: Guidewires for Rotablator Atherectomy Catheter Recalled - Medscape - Dec 01, 2015. (medscape.com)
  • Your surgeon then inserts an atherectomy catheter attached with a blade, grinding bit, or laser filament at its tip through the guide wire to the narrowed part of the artery which is used to scrape away the plaque. (apexcardio.com)
  • The company's orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. (csi360.com)
  • The report studies the global atherectomy devices market over the forecast period of 2017 to 2022. (euprwire.com)
  • The growth of the global atherectomy devices market can be attributed to the rising demand for minimally invasive surgical procedures and increase in research activities in the field of atherectomy across the world. (smarthealthcarenews.com)
  • Additionally, growing healthcare expenditure and rising prevalence of peripheral artery diseases (PAD) are likely to add novel opportunities for the global atherectomy devices market over the forecast period. (smarthealthcarenews.com)
  • Opportunities and threats faces by the existing vendors in Global "Atherectomy Devices " market. (smarthealthcarenews.com)
  • DCA, or directional coronary atherectomy is a minimally invasive procedure to remove blockage from coronary arteries to improve blood flow to the heart muscle and ease pain. (medlineplus.gov)
  • George Vetrovec, MD, presents highlights from a challenging live high-risk PCI case involving a severely calcified graft lesion successfully treated with orbital atherectomy and stenting with hemodynamic support from an Impella heart pump. (heartrecovery.com)
  • ST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patients in Canada have been treated with its Diamondback 360 ® Coronary Orbital Atherectomy System (OAS). (csi360.com)
  • SILVER SPRING, MD - Boston Scientific is voluntarily recalling two core wires for its Rotablator Rotational Atherectomy System, according to an alert from the US Food and Drug Administration (FDA) [ 1 ] . (medscape.com)
  • Jetstream™ is a rotational atherectomy system. (bostonscientific.com)
  • Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation. (cdc.gov)
  • Objectives We sought to assess plaque modification and stent expansion following orbital atherectomy (OA) for calcified lesions using optical coherence tomography (OCT). Background The efficacy of OA for treating calcified lesions is not well studied, especially using intravascular imaging in vivo. (octnews.org)
  • In this study, we report the immediate results and acute complications of treating bifurcation lesions in the coronary arteries with directional atherectomy in 9 patients, ranging in age from 33 to 60 (mean 56.7 +/- 10.8) years. (who.int)
  • In conclusion, directional atherectomy can be performed safely and successfully for dilatation of complex bifurcation lesions in the coronary arteries without any major complications using the double-wire or sequential atherectomy technique. (who.int)
  • It takes around two hours to complete an atherectomy procedure with additional time for preparation and recovery. (heartandstroke.ca)
  • Coronary Atherectomy is a procedure that removes fatty material (plaque) from your coronary arteries so more blood can get to your heart. (medmovie.com)
  • Plaque can be removed by a procedure called atherectomy. (apexcardio.com)
  • Directional atherectomy is a procedure during which the plaque in your coronary arteries is shaved from the arterial walls. (krishnacardiac.com)
  • Atherectomy is a surgical procedure which is performed to remove atherosclerotic plaque from diseased arteries, without affecting the rest vessel wall. (smarthealthcarenews.com)
  • Coronary atherectomy]] which is a 'percutaneous transluminal procedure for removing atheromatous plaque from the coronary arteries. (citizendium.org)
  • Atherectomy Devices Market 2022 The atherectomy devices market is likely to grow at a 8.10% CAGR during forecast, reveals the new Market Research Future (MRFR) report. (articlewood.com)
  • Atherectomy is useful in situations where hard plaque, with a lot of calcium, is blocking an artery. (heartandstroke.ca)
  • Factors such as increasing availability of reimbursements for atherectomy devices, growing adoption of atherectomy devices among medical professionals, large patient population of peripheral & coronary artery diseases, and growing number of clinical trials are driving the growth of the North American atherectomy devices market. (euprwire.com)
  • If you suffer from iliac vein compression, peripheral artery disease, or any other vascular condition, the first step is to contact an experienced Atherectomy Doctor and receive a proper diagnosis. (vividvascular.com)
  • A Single-Center Study Using IVUS to Guide Rotational Atherectomy for Chronic Renal Disease's Calcified Coronary Artery. (bvsalud.org)
  • During the second attempt the next day, rotational atherectomy was used for plaque modification as the lesion appeared fibrocalcific angiographically. (bmj.com)
  • The lesion was successfully ablated with orbital atherectomy and a stent was placed in the proximal graft yielding an excellent angiographic result. (heartrecovery.com)
  • Orbital atherectomy has demonstrated clinical advantages compared to alternative treatments, including low- rates of procedural complications and target lesion revascularization through 3-years. (csi360.com)
  • Micah Watts, MD, FSIR, and Sarang Mangalmurti, MD, FACC, share an overview of the mechanism of action of Phoenix atherectomy and the basics of IVUS image interpretation. (vumedi.com)
  • To assess the effectiveness and safety of an IVUS-guided rotational atherectomy (RA) percutaneous coronary intervention (PCI) in chronic renal patients with complex coronary calcification who are at risk for contrast-related acute kidney injury (AKI). (bvsalud.org)
  • Chest pain, ST segment elevation and slow flow are recognized as the complications of percutaneous transluminal coronary rotational atherectomy (PTCRA). (elsevier.com)
  • IMSEAR at SEARO: Directional atherectomy for the dilatation of bifurcation stenoses in the coronary arteries. (who.int)
  • Gambhir DS, Petkar S, Trehan V, Nair M, Bhargava M, Kumar RA, Khalilullah M. Directional atherectomy for the dilatation of bifurcation stenoses in the coronary arteries. (who.int)
  • Atherectomy is used to remove plague buildup from blocked or narrowed arteries. (valleyhealth.com)
  • The peripheral vascular applications segment accounted for the major share of the market owing to the significant availability of clinical evidence to support the therapeutic efficacy of atherectomy in PVD treatment and growing patient preference for minimally invasive surgical procedures. (euprwire.com)
  • The large share of this segment is attributed to increasing adoption of atherectomy for cardiac & peripheral vascular disease treatment, ongoing technological advancements in the field of minimally invasive or image-guided atherectomy procedures, rising incidence of chronic vascular diseases, and growing availability of healthcare reimbursements across major countries. (euprwire.com)
  • Our Atherectomy Doctor has successfully treated countless patients who suffered from a wide range of vascular conditions, and most procedures are completed in-house. (vividvascular.com)
  • Ra Medical Systems a medical device company focused on developing the excimer laser system to treat vascular diseases, has announced that enrollment has reached 95 subjects in the pivotal clinical trial to evaluate the safety and effectiveness of the DABRA excimer laser system as an atherectomy device for the treatment of peripheral arterial disease (PAD). (interventionalnews.com)
  • Dr. Arun Kalyanasundaram , one of India's renowned cardiologists, has successfully proctored Indias first laser atherectomy to treat a complex heart blockage in a middle aged woman at Raipur. (bharathanews.com)
  • CSI's orbital atherectomy technology enables effective calcium modification to facilitate full stent expansion. (csi360.com)
  • Annual operator volume among patients treated using percutaneous coronary interventions with rotational atherectomy and procedural outcomes : analysis based on a large national registry. (krakow.pl)
  • Jetstream is the only atherectomy device designed​ to treat it all . (bostonscientific.com)
  • In addition, OAS is optimized for efficiency as it allows bi-directional atherectomy in multiple vessel sizes with one device. (csi360.com)
  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Atherectomy And Thrombectomy Device market. (globalmarketmonitor.com)
  • The report deep analyzes type and application in Japan Atherectomy And Thrombectomy Device market. (globalmarketmonitor.com)
  • Detailed analysis of key players, along with key growth strategies adopted by Atherectomy And Thrombectomy Device industry, the PEST and SWOT analysis are also included. (globalmarketmonitor.com)
  • The report also provides exhaustive PEST analysis for all five regions after evaluating political, economic, social and technological factors effecting the Atherectomy Devices market. (smarthealthcarenews.com)
  • North America is expected to dominate the atherectomy devices market in 2017. (euprwire.com)
  • Dr. Arun Kalyanasundaram was the first proctor in United States for laser atherectomy and was involved in the seminal study where he proctored physicians in India (in 2017) and helped pave the way for its approval by DCGI. (bharathanews.com)
  • EMAILWIRE.COM, January 03, 2017 ) Atherectomy Devices Market, has been prepared based on an in-depth market analysis with inputs from industry experts. (emailwire.com)
  • Explore cases involving dissections, perforations, and atherectomy as well as less common complications such as longitudinal stent deformation, vasospasm, and air embolism. (cardiologyapps.com)
  • For patients in whom medical and exercise therapy fail or those who have claudication symptoms that are lifestyle-limiting, surgical treatment includes either open bypass surgery or endovascular therapy (eg, stents, balloons, or atherectomy devices). (medscape.com)
  • Grupo de técnicas percutáneas empleadas en el tratamiento de la OCLUSIÓN CORONARIA, incluyendo la angioplastia estándar con globo (ANGIOPLASTIA CORONARIA TRANSLUMINAL PERCUTÁNEA), la inserción de STENTS intracoronarios y las técnicas ateroablativas (p. ej. (bvsalud.org)
  • This can be attributed to the increasing prevalence of target diseases, increasing healthcare expenditure, cost-effective (owing to the increase in localized manufacturing and strengthening of distribution networks of key product manufacturers), and rising awareness among surgeons related to the benefits offered by atherectomy systems (less revascularization rates, high efficacy, short procedural time). (euprwire.com)
  • Atherectomy Devices Market Size was US$ 1.3 Billion in 2021. (updatesee.com)
  • Our Atherectomy Doctor can safely perform most procedures within the comfort of our Miami Beach office. (vividvascular.com)
  • According to a clinical expert consensus document on rotational atherectomy in China , both PCI procedures were performed. (bvsalud.org)
  • The open-label pivotal atherectomy clinical trial can enroll subjects with symptoms of PAD (Rutherford Class 2-5) at up to 10 sites. (interventionalnews.com)
  • Clinical Characteristics and Long-Term Outcomes of Rotational Atherectomy - J2T Multicenter Registry. (twmu.ac.jp)
  • Laser atherectomy is typically most appropriate for the removal of softer types of plaque. (wkhs.com)
  • Dr. Arun Kalyanasundaram was flown in from Chennai to help perform the case utilizing laser atherectomy. (bharathanews.com)
  • Atherectomy - The plaque is removed by using a rotating shaver or laser. (mednhealth.com)
  • On the basis of product, the market is segmented into rotational atherectomy systems, directional atherectomy systems, orbital atherectomy systems, photo-ablative (laser) atherectomy systems and support devices. (smarthealthcarenews.com)
  • Atherectomy devices assist surgeons in critical care of patients with arterial calcium build up. (portescap.com)
  • Atherectomy systems were developed with the intent of removing plaque and increasing arterial lumen size. (asme.org)
  • Atherectomy devices are effectively used in the treatment of coronary and peripheral arterial diseases. (smarthealthcarenews.com)
  • The report also analyzes factors affecting Atherectomy Devices market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. (smarthealthcarenews.com)
  • Atherectomy Devices Market " study by " The Insight Partners " provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years. (smarthealthcarenews.com)
  • While Dr. Shlofmitz wouldn't necessarily use an Impella on a vein graft case with normal LV function, in this case, with so much myocardium at risk and the need for atherectomy, if something unpredictable went wrong, he emphasizes, "we would have been in trouble, so I'm glad that we put the Impella in. (heartrecovery.com)
  • The report Atherectomy Devices Market gives varied description about the segmentation of the market on the basis of segmented type, application and region, and leads with a descriptive structure of the trends and restrictions of the various segments and sub segments. (smarthealthcarenews.com)
  • After your diagnosis, your Atherectomy Doctor will determine which treatment option is right for you. (vividvascular.com)
  • Best low-cost and yet high-quality Atherectomy for atherosclerosis treatment in Thailand for medical tourism patients. (2015medicaltourism.com)
  • Compare international Cardiothoracic surgery hospitals and ask about the total cost of the Atherectomy for atherosclerosis medical services in Thailand. (2015medicaltourism.com)